The protein biomarkers IGFBP2, DKK3, and PKM2 were previously identified and validated in an Australian cohort for their diagnostic potential, outperforming stool-based screening tests for detecting early stages of CRC [33]. This evidence concerns the gene IGFBP2 and colorectal carcinoma.